Search research articles
Contact Us
Filters
Showing results (91-100 of 311) with videos related to
Page
of 32
Sort By:
Seminars in Arthritis and Rheumatism
|
August 1, 1987
The cellular pharmacology of auranofin
R M Snyder, C K Mirabelli, S T Crooke
Biochemical Pharmacology
|
March 1, 1987
Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages
R M Snyder, C K Mirabelli, S T Crooke
The Biochemical Journal
|
September 1, 1988
Inhibition of formation of cyclic AMP and cyclic GMP by vasopressin in smooth-muscle cells is insensitive to pertussis toxin
P Nambi, M Whitman, N Aiyar, et al.
Cancer Research
|
November 1, 1980
Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs
C K Mirabelli, C H Huang, S T Crooke
Biochemical Pharmacology
|
March 15, 1986
Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions
R M Snyder, C K Mirabelli, S T Crooke
Molecular Pharmacology
|
September 1, 1979
DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule
V H DuVernay, J A Pachter, S T Crooke
Cancer Research
|
February 1, 1975
Ultrastructural study of the effect of bleomycin A2 on the nucleolus and its possibly related cytoplasmic constituents in Novikoff hepatoma cells
Y Daskal, S T Crooke, K Smetana, et al.
Cancer Research
|
February 1, 1980
Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin
V H DuVernay, J A Pachter, S T Crooke
Biochimica Et Biophysica Acta
|
January 16, 1990
Glycerol-3-phospho-D-myo-inositol 4-phosphate (Gro-PIP) is an inhibitor of phosphoinositide-specific phospholipase C
M Cruz-Rivera, C F Bennett, S T Crooke
Cancer Research
|
April 1, 1979
Purification and mechanism of action of macromomycin
T H Sawyer, A W Prestayko, S T Crooke
Page
of 32
Search research articles
Search
Showing results (91-100 of 311) with videos related to
Sort By:
Page
of 32
Seminars in Arthritis and Rheumatism
|
August 1, 1987
The cellular pharmacology of auranofin
R M Snyder, C K Mirabelli, S T Crooke
Biochemical Pharmacology
|
March 1, 1987
Cellular interactions of auranofin and a related gold complex with RAW 264.7 macrophages
R M Snyder, C K Mirabelli, S T Crooke
The Biochemical Journal
|
September 1, 1988
Inhibition of formation of cyclic AMP and cyclic GMP by vasopressin in smooth-muscle cells is insensitive to pertussis toxin
P Nambi, M Whitman, N Aiyar, et al.
Cancer Research
|
November 1, 1980
Comparison of DNA damage and single- and double-strand breakage activities on PM-2 DNA by talisomycin and bleomycin analogs
C K Mirabelli, C H Huang, S T Crooke
Biochemical Pharmacology
|
March 15, 1986
Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions
R M Snyder, C K Mirabelli, S T Crooke
Molecular Pharmacology
|
September 1, 1979
DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule
V H DuVernay, J A Pachter, S T Crooke
Cancer Research
|
February 1, 1975
Ultrastructural study of the effect of bleomycin A2 on the nucleolus and its possibly related cytoplasmic constituents in Novikoff hepatoma cells
Y Daskal, S T Crooke, K Smetana, et al.
Cancer Research
|
February 1, 1980
Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin
V H DuVernay, J A Pachter, S T Crooke
Biochimica Et Biophysica Acta
|
January 16, 1990
Glycerol-3-phospho-D-myo-inositol 4-phosphate (Gro-PIP) is an inhibitor of phosphoinositide-specific phospholipase C
M Cruz-Rivera, C F Bennett, S T Crooke
Cancer Research
|
April 1, 1979
Purification and mechanism of action of macromomycin
T H Sawyer, A W Prestayko, S T Crooke
Page
of 32